The story of Sildenafil presents a complex case for investors in the drug sector. While initially a blockbuster success, producing vast sums, the intellectual property expiration and the subsequent arrival of off-brand https://knockoff343584.loginblogin.com/49965525/viagra-and-pharma-a-risky-investment